Actively Recruiting
Rowing Following Breast Cancer Chemotherapy
Led by University of Florida · Updated on 2025-08-17
72
Participants Needed
1
Research Sites
117 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise intervention on cardiovascular rehabilitation in breast cancer survivors.
CONDITIONS
Official Title
Rowing Following Breast Cancer Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of primary invasive non-metastatic breast cancer, stages I-III
- Female based on biological sex
- Aged 40 to 80 years
- Completed breast cancer treatment 6 to 24 months prior to enrollment
- Adjuvant endocrine therapy and certain cancer-related medications allowed within 6 months prior and during study
- No contraindications to exercise or study participation
- Approval by study clinician
You will not qualify if you...
- Not meeting inclusion criteria
- Receiving or scheduled for breast cancer treatments like chemotherapy, surgery, or radiation during study
- Lymphedema stage 2 or higher before enrollment
- Relevant cardiovascular diseases such as stroke, heart failure, myocardial ischemia, myocardial infarction, angina, or heart surgeries
- Participation in other experimental interventions that could affect study results
- Regularly rowing for 150 minutes or more per week at moderate intensity in last 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Integrative Cardiovasculal Physiology Laboratory, University of Florida
Gainesville, Florida, United States, 32611
Actively Recruiting
Research Team
D
Demetra Christou, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here